Approval · Notice of Compliance 3141 · 1998
EVISTA: Notice of Compliance 3141
Issued November 6, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3141
- Date
- November 6, 1998
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Selective estrogen receptor modulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVISTA | 02239028 | Cancelled Post Market |
Medicinal ingredients
- RALOXIFENE HCL 60 MG per TAB